168 related articles for article (PubMed ID: 33961341)
21. Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis.
Lim SH; Park S; Jang JH; Kim K; Kim HJ; Kim SH; Kang CI; Chung DR; Peck KR; Lee J; Cha HS; Koh EM; Ko YH; Kim WS; Jung CW; Kim SJ
Ann Hematol; 2016 Jan; 95(2):325-35. PubMed ID: 26453074
[TBL] [Abstract][Full Text] [Related]
22. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.
Chan GW; Gorgun G; Miller KB; Foss FM
Biol Blood Marrow Transplant; 2003 Mar; 9(3):170-6. PubMed ID: 12652467
[TBL] [Abstract][Full Text] [Related]
23. [The clinical characteristics of adult hemophagocytic lymphohistiocytosis treated with haploidentical donor hematopoietic stem cell transplantation].
Fu L; Wei N; Wang JS; Wu L; Wang YN; Huang DY; Liu JL; Wang Z
Zhonghua Nei Ke Za Zhi; 2017 Apr; 56(4):273-278. PubMed ID: 28355720
[No Abstract] [Full Text] [Related]
24. The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation.
Kim SJ; Park S; Rhu J; Kim JM; Choi GS; Joh JW
Sci Rep; 2022 Nov; 12(1):20337. PubMed ID: 36434131
[TBL] [Abstract][Full Text] [Related]
25. [Sucecesfull bone marrow transplantation in a case of familial hemophagocytic lymphohistiocytosis type 3].
Caicedo-Herrera G; Candelo E; Olaya M; Pérez P; Medina D; Pachajoa H
Andes Pediatr; 2021 Apr; 92(2):269-273. PubMed ID: 34106167
[TBL] [Abstract][Full Text] [Related]
26. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.
Dandu H; Yadav G; Malhotra HS; Pandey S; Sachu R; Dubey K
Int J Lab Hematol; 2021 Dec; 43(6):1291-1301. PubMed ID: 34086418
[TBL] [Abstract][Full Text] [Related]
27. Modeling acute graft-versus-host disease (aGVHD) in murine bone marrow transplantation (BMT) models with MHC disparity.
Scheurer J; Leithäuser F; Debatin KM; Strauss G
Methods Cell Biol; 2022; 168():19-39. PubMed ID: 35366982
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Schwinghammer TL; Bloom EJ
Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
[TBL] [Abstract][Full Text] [Related]
29. Graft-versus-host disease of the central nervous system after liver transplantation: A rare complication.
Pahari H; Nagai S; Skorupski S; Salgia R
Am J Transplant; 2018 Oct; 18(10):2591-2594. PubMed ID: 29935052
[TBL] [Abstract][Full Text] [Related]
30. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.
Spitzer TR; McAfee S; Sackstein R; Colby C; Toh HC; Multani P; Saidman S; Weyouth DW; Preffer F; Poliquin C; Foley A; Cox B; Andrews D; Sachs DH; Sykes M
Biol Blood Marrow Transplant; 2000; 6(3A):309-20. PubMed ID: 10905768
[TBL] [Abstract][Full Text] [Related]
31. Hemophagocytic lymphohistiocytosis and myelodysplastic syndrome: a case report and review of the literature.
Sun Y; Blieden C; Merritt BY; Sosa R; Rivero G
J Med Case Rep; 2021 Mar; 15(1):98. PubMed ID: 33648567
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial.
Wagner JE; Santos GW; Noga SJ; Rowley SD; Davis J; Vogelsang GB; Farmer ER; Zehnbauer BA; Saral R; Donnenberg AD
Blood; 1990 Mar; 75(6):1370-7. PubMed ID: 2310834
[TBL] [Abstract][Full Text] [Related]
33. Post-Transfusion Hemophagocytosis Without Hemophagocytic Lymphohistiocytosis.
McGinnis E; Medvedev N; Richards MJ; Chen LYC; Wong MP
Mayo Clin Proc Innov Qual Outcomes; 2019 Dec; 3(4):517-522. PubMed ID: 31993572
[TBL] [Abstract][Full Text] [Related]
34. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
Min CK; Kim DW; Lee JW; Min WS; Kim CC
Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
[TBL] [Abstract][Full Text] [Related]
35. Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host disease.
Gyger M; Baron C; Forest L; Lussier P; Lagacé F; Bissonnette I; Bélanger R; Bonny Y; Busque L; Roy DC; Perreault C
Exp Hematol; 1998 May; 26(5):426-34. PubMed ID: 9590660
[TBL] [Abstract][Full Text] [Related]
36. Hematopoietic Dysfunction during Graft-Versus-Host Disease: A Self-Destructive Process?
Müskens KF; Lindemans CA; Belderbos ME
Cells; 2021 Aug; 10(8):. PubMed ID: 34440819
[TBL] [Abstract][Full Text] [Related]
37. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
38. Hemophagocytic lymphohistiocytosis as an etiology of bone marrow failure.
Paolino J; Berliner N; Degar B
Front Oncol; 2022; 12():1016318. PubMed ID: 36387094
[TBL] [Abstract][Full Text] [Related]
39. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
40. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
